Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H3FN2O2 |
Molecular Weight | 130.0772 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CNC(=O)NC1=O
InChI
InChIKey=GHASVSINZRGABV-UHFFFAOYSA-N
InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
Molecular Formula | C4H3FN2O2 |
Molecular Weight | 130.0772 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:09:22 UTC 2023
by
admin
on
Fri Dec 15 15:09:22 UTC 2023
|
Record UNII |
U3P01618RT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548781
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
NCI_THESAURUS |
C1557
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
WHO-ATC |
L01BC02
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
IARC | 5-Fluorouracil | ||
|
FDA ORPHAN DRUG |
40589
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
13.4
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
WHO-ATC |
L01BC52
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
42289
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
WHO-VATC |
QL01BC02
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
NDF-RT |
N0000000233
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
NCI_THESAURUS |
C2021
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
WHO-VATC |
QL01BC52
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/00/004
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
32088
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
NDF-RT |
N0000175595
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
131799
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
19893
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
m5483
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | Merck Index | ||
|
U3P01618RT
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
FLUOROURACIL
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
200-085-6
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
FLUOROURACIL
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder. Solubility: Sparingly soluble in water; slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Cytotoxic drug. Storage: Fluorouracil should be kept in a tightly closed container, protected from light. Additional information: Fluorouracil melts at about 282?C with decomposition. CAUTION: Fluorouracil must be handled with care, avoiding contact with the skin and inhalation of airborne particles. Definition: Fluorouracil contains not less than 98.5% and not more than 101.0% of C4H3FN2O2, calculated with reference to the dried substance. | ||
|
D005472
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
26
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
CHEMBL185
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
C505
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
SUB07721MIG
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
3385
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
DTXSID2020634
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
1279000
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
46345
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
U3P01618RT
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
3228
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
4789
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
4492
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000091592
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
Fluorouracil
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
51-21-8
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
1421
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY | |||
|
DB00544
Created by
admin on Fri Dec 15 15:09:22 UTC 2023 , Edited by admin on Fri Dec 15 15:09:22 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TARGET -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE |
Down-regulation of ABCB5αresulted in a gain of drug sensitivity to camptothecin 10-OH, 5-fluorouracil, and mitoxantrone.
|
||
|
EXCRETED UNCHANGED |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE ACTIVE -> PRODRUG | |||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE INACTIVE -> PARENT | |||
|
PRODRUG -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 1.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 1.5
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|